Allergan marketplaces a portfolio of best-in-class products offering valuable remedies for the central anxious system, eye care, medical aesthetics, gastroenterology, women’s health, urology, anti-infective and cardiovascular therapeutic categories, and operates the world’s third-largest global generics business, providing patients around the globe with increased usage of affordable, high-quality medicines. Allergan is an industry leader in research and development, with among the broadest development pipelines in the pharmaceutical industry and a leading position in the submission of generic item applications globally. The directors of Allergan accept responsibility for the info within this announcement.This unique system will simplify and accelerate the transition from qualitative evaluation to quantitative analysis within the same system for more conclusive outcomes from complex samples. The AB SCIEX platform is likely to advance a true amount of mass spectrometry applications, such as metabolite identification for drug development and discovery; proteomics for biomarker and proteins research; and general unidentified screening of chemical substances for meals and environmental assessment. The collaboration with the University of Geneva can help establish the step-by-step procedures of analysis that will improve metabolism research to generate the most complete data.